Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2008-05-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606
Influence of Protein Source on Satiety and Metabolism
NCT00862329
Dairy Proteins and Postprandial Appetite Regulation and Energy Expenditure
NCT01133964
Satiety Effects of Protein and Fiber Added to Pasta
NCT01792596
Satiating Effects of Isolated Soy Proteins
NCT01731197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whey protein
Complete whey protein.
Whey
Preload containing complete whey protein.
Whey-CMP
Complete whey protein missing the CMP (aka GMP) portion of the peptide.
Whey-CMP
Preload containing complete whey protein which is missing the CMP/GMP portion of the protein.
Control
Placebo preload control, matched for energy.
Control
Preload control matched for energy to the other 5 preloads.
CMP (casinomacropeptide)
Small peptide cleaved from complete whey protein.
CMP
Preload containing the CMP (casinomacropeptide) portion cleaved from complete whey protein.
MPI
Complete milk protein.
MPI
Preload containing whole milk protein.
CPI (casein)
Preload containing casein.
CPI
Preload containing sodium caseinate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey
Preload containing complete whey protein.
Whey-CMP
Preload containing complete whey protein which is missing the CMP/GMP portion of the protein.
Control
Preload control matched for energy to the other 5 preloads.
CMP
Preload containing the CMP (casinomacropeptide) portion cleaved from complete whey protein.
MPI
Preload containing whole milk protein.
CPI
Preload containing sodium caseinate.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unrestrained (score ≤ 10 on the Eating Inventory (EI) questionnaire, Stunkard and Messick 1985)
* Women
* 18 years of age
* Consume a low/moderate protein diet (12-20% protein energy).
* Meet BMI criteria of 19 to 24 kg/m2 OR 29 to 34 kg/m2, inclusive.
Exclusion Criteria
* Women who score ≥ 30 on Eating Attitudes Test (EAT, Garner and Garfinkel 1979),
* Have current or past (previous 1 year) medical conditions that may interfere with any of the outcomes of this study.
* Weigh less than 110 lbs
* Are currently or have been modifying diet or exercise patterns to gain or lose weight in previous 60 days
* Have unstable body weight (fluctuations of ≥ 5 kg in 60 day period)
* Are excessive exercisers or trained athletes
* Taking any medications that would affect appetite or any other study-described endpoint will also be excluded.
* Allergies or intolerances to foods consumed in the study.
* Smoker
* Pregnant/lactation
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Britt Burton-Freeman, PhD, MS
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis (Ragle Human Nutrition Research Center)
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200614016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.